SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 76 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,000 | +50.0% | 10,200 | +37.6% | 0.00% | – |
| Q1 2016 | $4,000 | -42.9% | 7,411 | -15.5% | 0.00% | – |
| Q4 2015 | $7,000 | +133.3% | 8,767 | +136.9% | 0.00% | – |
| Q3 2015 | $3,000 | +200.0% | 3,700 | +1133.3% | 0.00% | – |
| Q2 2015 | $1,000 | -96.8% | 300 | -97.6% | 0.00% | – |
| Q1 2015 | $31,000 | +19.2% | 12,480 | +25.3% | 0.00% | – |
| Q4 2014 | $26,000 | +116.7% | 9,962 | +479.2% | 0.00% | – |
| Q3 2014 | $12,000 | -14.3% | 1,720 | -19.9% | 0.00% | – |
| Q2 2014 | $14,000 | -94.8% | 2,146 | -94.7% | 0.00% | – |
| Q1 2014 | $268,000 | +219.0% | 40,663 | +130.8% | 0.00% | – |
| Q4 2013 | $84,000 | +740.0% | 17,615 | +771.6% | 0.00% | – |
| Q3 2013 | $10,000 | – | 2,021 | +4711.9% | 0.00% | – |
| Q2 2013 | $0 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |